The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Interplay between biofilm microenvironment and pathogenicity of Pseudomonas aeruginosa in cystic fibrosis lung chronic infection
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Experimental and clinical studies show that CF-adapted airway biofilms display elevated tolerance to several classes of antibiotics, which links biofilm behavior to progressive lung disease [5,6].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extracellular DNA Required for Bacterial Biofilm Formation
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C., & Mattick, J. S. (2002) · Science · doi:10.1126/science.295.5559.1487 · Cited by 2,203
Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilms
Turnbull, L., Toyofuku, M., Hynen, A. L., Kurosawa, M., Pessi, G., Petty, N. K., Osvath, S. R., Cárcamo-Oyarce, G., Gloag, E. S., Shimoni, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11220 · Cited by 709
Responses of microorganisms to osmotic stress.
Bremer, E., & Krämer, R. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115504 · Cited by 463
Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection
Korgaonkar, A., Trivedi, U., Rumbaugh, K. P., & Whiteley, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214550110 · Cited by 315
In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp.
Hotterbeekx, A., Kumar-Singh, S., Goossens, H., & Malhotra-Kumar, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00106 · Cited by 289
Research works printed but not linked: 130
- Hilker, 2015, Interclonal gradient of virulence in the Pseudomonas aeruginosa pangenome from disease and environment, Environ Microbiol, 17, 29, 10.1111/1462-2920.12606 · DOI
- Jennings, 2021, Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies, Cell Rep, 34, 10.1016/j.celrep.2021.108782 · DOI · Paper page
- Høiby, 2011, Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis, BMC Med, 9, 32, 10.1186/1741-7015-9-32 · DOI · Paper page
- Rau, 2010, Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts, Environ Microbiol, 12, 1643, 10.1111/j.1462-2920.2010.02211.x · DOI
- Barclay, 1996, Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis, J Antimicrob Chemother, 37, 1155, 10.1093/jac/37.6.1155 · DOI
- Fernández, 2010, Adaptive resistance to the “last hope” antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS, Antimicrob Agents Chemother, 54, 3372, 10.1128/AAC.00242-10 · DOI · Paper page
- MacLeod, 2000, Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment, J Infect Dis, 181, 1180, 10.1086/315312 · DOI
- Hentzer, 2001, Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function, J Bacteriol, 183, 5395, 10.1128/JB.183.18.5395-5401.2001 · DOI · Paper page
- Cookson, 2018, New opportunities for managing acute and chronic lung infections, Nat Rev Microbiol, 16, 111, 10.1038/nrmicro.2017.122 · DOI
- Mahenthiralingam, 2014, Emerging cystic fibrosis pathogens and the microbiome, Paediatr Respir Rev, 15, 13
- Bittar, 2010, Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients, Clin Microbiol Infect, 16, 809, 10.1111/j.1469-0691.2010.03236.x · DOI
- Ma, 2022, Regulation of biofilm exopolysaccharide biosynthesis and degradation in Pseudomonas aeruginosa, Annu Rev Microbiol, 76, 10.1146/annurev-micro-041320-111355 · DOI
- Hoiby, 2010, Pseudomonas aeruginosa biofilms in cystic fibrosis, Future Microbiol, 5, 1663, 10.2217/fmb.10.125 · DOI · Paper page
- Doggett, 1969, Incidence of mucoid Pseudomonas aeruginosa from clinical sources, Appl Microbiol, 18, 936, 10.1128/am.18.5.936-937.1969 · doi:10.1128/am.18.5.936-937.1969
- Linker, 1964, A polysaccharide resembling alginic acid from a Pseudomonas micro-organism, Nature, 204, 187, 10.1038/204187a0 · DOI · Paper page
- Evans, 1973, Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa, J Bacteriol, 116, 915, 10.1128/jb.116.2.915-924.1973 · DOI · Paper page
- May, 1991, Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients, Clin Microbiol Rev, 4, 191, 10.1128/CMR.4.2.191 · DOI · Paper page
- Lee, 2005, Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis, J Clin Microbiol, 43, 5247, 10.1128/JCM.43.10.5247-5255.2005 · DOI
- Guo, 2020, Structures, properties and application of alginic acid: a review, Int J Biol Macromol, 162, 618, 10.1016/j.ijbiomac.2020.06.180 · DOI · Paper page
- Massip-Copiz, 2018, Extracellular pH and lung infections in cystic fibrosis, Eur J Cell Biol, 97, 402, 10.1016/j.ejcb.2018.06.001 · DOI
- Ojoo, 2005, Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis, Thorax, 60, 22, 10.1136/thx.2003.017327 · DOI · Paper page
- Braccini, 1999, Conformational and configurational features of acidic polysaccharides and their interactions with calcium ions: a molecular modeling investigation, Carbohydr Res, 317, 119, 10.1016/S0008-6215(99)00062-2 · DOI · Paper page
- Smith, 2014, Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity, J Cyst Fibros, 13, 289, 10.1016/j.jcf.2013.12.001 · DOI
- Lam, 1980, Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis, Infect Immun, 28, 546, 10.1128/iai.28.2.546-556.1980 · DOI · Paper page
- Gordon, 1988, Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa, J Antimicrob Chemother, 22, 667, 10.1093/jac/22.5.667 · DOI · Paper page
- Nichols, 1988, Inhibition of tobramycin diffusion by binding to alginate, Antimicrob Agents Chemother, 32, 518, 10.1128/AAC.32.4.518 · DOI · Paper page
- lannuccelli, 1996, Biodegradable intraoperative system for bone infection treatment. I. The drug/polymer interaction, Int J Pharm, 143, 195, 10.1016/S0378-5173(96)04703-5 · DOI
- Heriot, 2019, Interaction of gentamicin sulfate with alginate and consequences on the physico-chemical properties of alginate-containing biofilms, Int J Biol Macromol, 121, 390, 10.1016/j.ijbiomac.2018.10.025 · DOI
- Song, 2014, Stiffness of cross-linked poly(dimethylsiloxane) affects bacterial adhesion and antibiotic susceptibility of attached cells, Langmuir, 30, 10354, 10.1021/la502029f · DOI
- Chanasit, 2020, Analysis of the alginate O-acetylation machinery in Pseudomonas aeruginosa, Appl Microbiol Biotechnol, 104, 2179, 10.1007/s00253-019-10310-6 · DOI
- Mayer, 1999, The role of intermolecular interactions: studies on model systems for bacterial biofilms, Int J Biol Macromol, 26, 3, 10.1016/S0141-8130(99)00057-4 · DOI · Paper page
- DiRita, 2001, Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis, Infect Immun, 69, 1895, 10.1128/IAI.69.3.1895-1901.2001 · DOI · Paper page
- Ertesvåg, 2015, Alginate-modifying enzymes: biological roles and biotechnological uses, Front Microbiol, 6
- Lamppa, 2013, Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy, Antimicrob Agents Chemother, 57, 137, 10.1128/AAC.01789-12 · DOI
- Skjåk-Bræk, 1989, Effect of acetylation on some solution and gelling properties of alginates, Carbohydr Res, 185, 131, 10.1016/0008-6215(89)84028-5 · DOI
- Boucher, 2007, Evidence for airway surface dehydration as the initiating event in CF airway disease, J Intern Med, 261, 5, 10.1111/j.1365-2796.2006.01744.x · DOI · Paper page
- Schnider-Keel, 2001, The sigma factor AlgU (AlgT) controls exopolysaccharide production and tolerance towards desiccation and osmotic stress in the biocontrol agent Pseudomonas fluorescens CHA0, Appl Environ Microbiol, 67, 5683, 10.1128/AEM.67.12.5683-5693.2001 · DOI
- DeVault, 1990, Pulmonary dehydration and infection in cystic fibrosis: evidence that ethanol activates alginate gene expression and induction of mucoidy in Pseudomonas aeruginosa, Mol Microbiol, 4, 737, 10.1111/j.1365-2958.1990.tb00644.x · DOI
- Tashiro, 2014, Low concentrations of ethanol stimulate biofilm and pellicle formation in Pseudomonas aeruginosa, Biosci Biotechnol Biochem, 78, 178, 10.1080/09168451.2014.877828 · doi:10.1080/09168451.2014.877828
- Ibáñez de Aldecoa, 2017, Mechanisms and regulation of extracellular DNA release and its biological roles in microbial communities, Front Microbiol, 8, 10.3389/fmicb.2017.01390 · DOI · Paper page
- Potter, 1969, Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy, Am Rev Respir Dis, 99, 909
- Shah, 1996, In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis, Thorax, 51, 119, 10.1136/thx.51.2.119 · DOI
- Picot, 1978, Pus, deoxyribonucleic acid, and sputum viscosity, Thorax, 33, 235, 10.1136/thx.33.2.235 · doi:10.1136/thx.33.2.235
- Mulcahy, 2008, Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms, PLoS Pathog, 4, 10.1371/journal.ppat.1000213 · DOI · Paper page
- Egli, 2002, DNA-cation interactions: quo vadis?, Chem Biol, 9, 277, 10.1016/S1074-5521(02)00116-3 · DOI · Paper page
- Dobi, 1998, Submillimolar levels of calcium regulates DNA structure at the dinucleotide repeat (TG/AC)n, Proc Natl Acad Sci U S A, 95, 5981, 10.1073/pnas.95.11.5981 · DOI
- Powell, 2018, Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides, NPJ Biofilms Microbiomes, 4, 13, 10.1038/s41522-018-0056-3 · DOI · Paper page
- Alhede, 2020, The origin of extracellular DNA in bacterial biofilm infections in vivo, Pathog Dis, 78, 10.1093/femspd/ftaa018 · DOI
- Chiang, 2013, Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 57, 2352, 10.1128/AAC.00001-13 · DOI · Paper page
- Allesen-Holm, 2006, A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms, Mol Microbiol, 59, 1114, 10.1111/j.1365-2958.2005.05008.x · DOI · Paper page
- Lethem, 1990, The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum, Eur Respir J, 3, 19, 10.1183/09031936.93.03010019 · DOI · Paper page
- Martínez-Alemán, 2017, Understanding the entanglement: neutrophil extracellular traps (NETs) in cystic fibrosis, Front Cell Infect Microbiol, 7, 10.3389/fcimb.2017.00104 · DOI
- Wang, 2015, The exopolysaccharide Psl-eDNA interaction enables the formation of a biofilm skeleton in Pseudomonas aeruginosa, Environ Microbiol Rep, 7, 330, 10.1111/1758-2229.12252 · DOI · Paper page
- Seviour, 2021, The biofilm matrix scaffold of Pseudomonas aeruginosa contains G-quadruplex extracellular DNA structures, Npj Biofilms Microbi, 7, 10.1038/s41522-021-00197-5 · DOI
- Dell'Anno, 2005, Extracellular DNA plays a key role in deep-sea ecosystem functioning, Science, 309, 10.1126/science.1117475 · DOI · Paper page
- Mulcahy, 2010, Pseudomonas aeruginosa produces an extracellular deoxyribonuclease that is required for utilization of DNA as a nutrient source, Environ Microbiol, 12, 1621, 10.1111/j.1462-2920.2010.02208.x · DOI · Paper page
- Prudhomme, 2006, Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae, Science, 313, 89, 10.1126/science.1127912 · DOI · Paper page
- Rajendran, 2013, Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms, Eukaryot Cell, 12, 420, 10.1128/EC.00287-12 · DOI · Paper page
- Freschi, 2018, The Pseudomonas aeruginosa pan-genome provides new insights on its population structure, horizontal gene transfer, and pathogenicity, Genome Biology and Evolution, 11, 109, 10.1093/gbe/evy259 · DOI · Paper page
- Qiu, 2009, Role of horizontal gene transfer in the evolution of Pseudomonas aeruginosa virulence, Genome Dyn, 6, 126, 10.1159/000235767 · DOI
- Wilton, 2016, Extracellular DNA acidifies biofilms and induces aminoglycoside resistance in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 60, 544, 10.1128/AAC.01650-15 · DOI · Paper page
- Friedman, 2004, Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms, Mol Microbiol, 51, 675, 10.1046/j.1365-2958.2003.03877.x · DOI · Paper page
- Jennings, 2015, Pel is a cationic exopolysaccharide that cross-links extracellular DNA in the Pseudomonas aeruginosa biofilm matrix, Proc Natl Acad Sci USA, 112, 11353, 10.1073/pnas.1503058112 · DOI · Paper page
- Häussler, 2009, New perspectives at the heart of surface-associated microbial communities, J Bacteriol, 192, 2941, 10.1128/JB.00332-10 · DOI
- Colvin, 2011, The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa, PLoS Pathog, 7, 10.1371/journal.ppat.1001264 · DOI · Paper page
- Madsen, 2015, Facultative control of matrix production optimizes competitive fitness in Pseudomonas aeruginosa PA14 biofilm models, Appl Environ Microbiol, 81, 8414, 10.1128/AEM.02628-15 · DOI
- Yoon, 2002, Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis, Dev Cell, 3, 593, 10.1016/S1534-5807(02)00295-2 · DOI · Paper page
- Montgomery, 2017, Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies, Eur Respir J, 49, 10.1183/13993003.00903-2016 · DOI
- Borriello, 2004, Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms, Antimicrob Agents Chemother, 48, 2659, 10.1128/AAC.48.7.2659-2664.2004 · DOI · Paper page
- Khan, 2010, Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide, Int Microbiol, 13, 207
- Friedman, 2004, Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix, J Bacteriol, 186, 4457, 10.1128/JB.186.14.4457-4465.2004 · DOI · Paper page
- Ma, 2007, Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide, J Bacteriol, 189, 8353, 10.1128/JB.00620-07 · DOI · Paper page
- Byrd, 2009, Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production, Mol Microbiol, 73, 622, 10.1111/j.1365-2958.2009.06795.x · DOI · Paper page
- Ma, 2012, Synthesis of multiple Pseudomonas aeruginosa biofilm matrix exopolysaccharides is post-transcriptionally regulated, Environ Microbiol, 14, 1995, 10.1111/j.1462-2920.2012.02753.x · DOI
- Colvin, 2012, The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix, Environ Microbiol, 14, 1913, 10.1111/j.1462-2920.2011.02657.x · DOI · Paper page
- Kovach, 2017, Evolutionary adaptations of biofilms infecting cystic fibrosis lungs promote mechanical toughness by adjusting polysaccharide production, Npj Biofilms Microbi, 3, 1, 10.1038/s41522-016-0007-9 · DOI
- Ma, 2009, Assembly and development of the Pseudomonas aeruginosa biofilm matrix, PLoS Pathog, 5, 10.1371/journal.ppat.1000354 · DOI · Paper page
- Mishra, 2012, Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization, Cell Microbiol, 14, 95, 10.1111/j.1462-5822.2011.01704.x · DOI · Paper page
- Jones, 2017, Psl produced by mucoid Pseudomonas aeruginosa contributes to the establishment of biofilms and immune evasion, mBio, 8, 10.1128/mBio.00864-17 · DOI
- Borlee, 2010, Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix, Mol Microbiol, 75, 827, 10.1111/j.1365-2958.2009.06991.x · DOI · Paper page
- Reichhardt, 2018, CdrA interactions within the Pseudomonas aeruginosa biofilm matrix safeguard it from proteolysis and promote cellular packing, mBio, 9, 10.1128/mBio.01376-18 · DOI
- Passos da Silva, 2019, The Pseudomonas aeruginosa lectin LecB binds to the exopolysaccharide Psl and stabilizes the biofilm matrix, Nat Commun, 10, 2183, 10.1038/s41467-019-10201-4 · DOI · Paper page
- Geddes-McAlister, 2019, Tasked with a challenging objective: why do neutrophils fail to battle Pseudomonas aeruginosa biofilms, Pathogens, 8, 283, 10.3390/pathogens8040283 · DOI
- Govan, 1996, Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia, Microbiol Rev, 60, 539, 10.1128/mr.60.3.539-574.1996 · doi:10.1128/mr.60.3.539-574.1996 · Paper page
- Billings, 2013, The extracellular matrix component psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilms, PLoS Pathog, 9, 10.1371/journal.ppat.1003526 · DOI · Paper page
- Hansson, 2019, Mucus and mucins in diseases of the intestinal and respiratory tracts, J Intern Med, 285, 479, 10.1111/joim.12910 · DOI · Paper page
- Bromberg, 1999, Aggregation phenomena in aqueous solutions of hydrophobically modified polyelectrolytes, A Probe Solubilization Study, Macromolecules, 32, 3649, 10.1021/ma981946k · DOI
- Raynal, 2002, Concentrated solutions of salivary MUC5B mucin do not replicate the gel-forming properties of saliva, Biochem J, 362 Pt 2, 289, 10.1042/bj3620289 · DOI
- Schipper, 2007, Saliva as research material: biochemical, physicochemical and practical aspects, Arch Oral Biol, 52, 1114, 10.1016/j.archoralbio.2007.06.009 · DOI · Paper page
- Petrou, 2018, Mucins as multifunctional building blocks of biomaterials, Biomater Sci, 6, 2282, 10.1039/C8BM00471D · DOI · Paper page
- Mitri, 2020, Novel anti-inflammatory approaches for cystic fibrosis lung disease: identification of molecular targets and design of innovative therapies, Front Pharmacol, 11, 1096, 10.3389/fphar.2020.01096 · DOI
- Song, 2003, Interleukin-1β and tumor necrosis factor-α induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells, J Biol Chem, 278, 23243, 10.1074/jbc.M300096200 · DOI · Paper page
- Yeung, 2012, Mucin promotes rapid surface motility in Pseudomonas aeruginosa, mBio, 3, 10.1128/mBio.00073-12 · DOI
- Landry, 2006, Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance, Mol Microbiol, 59, 142, 10.1111/j.1365-2958.2005.04941.x · DOI · Paper page
- Haley, 2012, Characterization of biofilm-like structures formed by Pseudomonas aeruginosa in a synthetic mucus medium, BMC Microbiol, 12, 10.1186/1471-2180-12-181 · DOI
- Co, 2018, Mucins trigger dispersal of Pseudomonas aeruginosa biofilms, Npj Biofilms Microbi, 4, 23, 10.1038/s41522-018-0067-0 · DOI · Paper page
- Van den Bossche, 2021, The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects, Eur Respir Rev, 30, 10.1183/16000617.0055-2021 · DOI
- Baos, 2012, Distribution of sialic acids on mucins and gels: a defense mechanism, Biophys J, 102, 176, 10.1016/j.bpj.2011.08.058 · DOI
- Kim, 2020, N-glycan modifications with negative charge in a natural polymer mucin from bovine submaxillary glands, and their structural role, Polymers (Basel), 13, 10.3390/polym13010103 · DOI
- Huang, 2015, Mucin binding reduces colistin antimicrobial activity, Antimicrob Agents Chemother, 59, 5925, 10.1128/AAC.00808-15 · DOI
- Samad, 2019, Mucus and mucin environments reduce the efficacy of polymyxin and fluoroquinolone antibiotics against Pseudomonas aeruginosa, ACS Biomater Sci Eng, 5, 1189, 10.1021/acsbiomaterials.8b01054 · DOI
- Grainger, 2006, Culture of calu-3 cells at the air interface provides a representative model of the airway epithelial barrier, Pharmaceut Res, 23, 1482, 10.1007/s11095-006-0255-0 · DOI · Paper page
- Lock, 2018, Mucus models to evaluate the diffusion of drugs and particles, Adv Drug Deliv Rev, 124, 34, 10.1016/j.addr.2017.11.001 · DOI · Paper page
- Pacheco, 2019, Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery, J Mater Chem B, 7, 4940, 10.1039/C9TB00957D · DOI
- Bhat, 1996, Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology, J Pharmacol Sci, 85, 624, 10.1021/js950381s · DOI
- Butnarasu, 2022, Cystic fibrosis mucus model to design more efficient drug therapies, Mol Pharm, 19, 520, 10.1021/acs.molpharmaceut.1c00644 · DOI
- Petri, 2003, Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo, Drug Metab Dispos, 31, 805, 10.1124/dmd.31.6.805 · DOI · Paper page
- Bhattacharjee, 2017, Nanoparticle passage through porcine jejunal mucus: microfluidics and rheology, Nanomed Nanotechnol Biol Med, 13, 863, 10.1016/j.nano.2016.11.017 · DOI
- Boegh, 2014, Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption, Eur J Pharm Biopharm, 87, 227, 10.1016/j.ejpb.2014.01.001 · DOI
- Falavigna, 2018, Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): an artificial permeability tool for drug screening and formulation development, Int J Pharm, 537, 213, 10.1016/j.ijpharm.2017.12.038 · DOI
- Wang, 2021, Mucin glycans signal through the sensor kinase RetS to inhibit virulence-associated traits in Pseudomonas aeruginosa, Curr Biol, 31, 90, 10.1016/j.cub.2020.09.088 · DOI
- Morrison, 2019, Mucus, mucins, and cystic fibrosis, Pediatr Pulmonol, 54, S84
- Wheeler, 2019, Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection, Nat Microbiol, 4, 2146, 10.1038/s41564-019-0581-8 · DOI · Paper page
- Hoffman, 2020, Host mucin is exploited by Pseudomonas aeruginosa to provide monosaccharides required for a successful infection, mBio, 11, 10.1128/mBio.00060-20 · DOI
- Tang, 2016, Acidic pH increases airway surface liquid viscosity in cystic fibrosis, J Clin Invest, 126, 879, 10.1172/JCI83922 · DOI · Paper page
- Smith, 2013, Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis, Eur Respir J, 42, 1723, 10.1183/09031936.00124012 · DOI
- Tyrrell, 2016, Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies, Microbiology, 162, 191, 10.1099/mic.0.000220 · DOI · Paper page
- Dieppois, 2012, The transcriptional regulator CzcR modulates antibiotic resistance and quorum sensing in Pseudomonas aeruginosa, PLoS One, 7, 10.1371/journal.pone.0038148 · DOI
- Aspedon, 2006, Microarray analysis of the osmotic stress response in Pseudomonas aeruginosa, J Bacteriol, 188, 2721, 10.1128/JB.188.7.2721-2725.2006 · DOI
- Price-Whelan, 2006, Rethinking 'secondary' metabolism: physiological roles for phenazine antibiotics, Nat Chem Biol, 2, 71, 10.1038/nchembio764 · DOI · Paper page
- Mavrodi, 2001, Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1, J Bacteriol, 183, 6454, 10.1128/JB.183.21.6454-6465.2001 · DOI · Paper page
- Lauredo, 1998, Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways, J Appl Physiol, 85, 2298, 10.1152/jappl.1998.85.6.2298 · DOI
- Lau, 2004, Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice, Infect Immun, 72, 4275, 10.1128/IAI.72.7.4275-4278.2004 · DOI · Paper page
- Das, 2015, Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation, Sci Rep-Uk, 5, 8398, 10.1038/srep08398 · DOI · Paper page
- Mah, 2003, A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance, Nature, 426, 306, 10.1038/nature02122 · DOI · Paper page
- Sadovskaya, 2010, High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: the ndvB gene is involved in the production of highly glycerol-phosphorylated β-(1→3)-glucans, which bind aminoglycosides, Glycobiology, 20, 895, 10.1093/glycob/cwq047 · DOI
- Scoffone, 2019, Quorum sensing as antivirulence target in cystic fibrosis pathogens, Int J Mol Sci, 20, 1838, 10.3390/ijms20081838 · DOI
- Balasubramanian, 2012, A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence, Nucleic Acids Res, 41, 1, 10.1093/nar/gks1039 · DOI · Paper page
- Briaud, 2020, Impact of coexistence phenotype between Staphylococcus aureus and Pseudomonas aeruginosa isolates on clinical outcomes among cystic fibrosis patients, Front Cell Infect Microbiol, 10, 266, 10.3389/fcimb.2020.00266 · DOI
- Camus, 2021, How bacterial adaptation to cystic fibrosis environment shapes interactions between Pseudomonas aeruginosa and Staphylococcus aureus, Front Microbiol, 12, 10.3389/fmicb.2021.617784 · DOI
Cited by
Mechanisms of antimicrobial resistance in biofilms
Liu, H. Y., Prentice, E. L., & Webber, M. A. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00046-3 · Cited by 545
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Metadata
- Authors
- Guillaume, O., Butnarasu, C., Visentin, S., & Reimhult, E.
- ORCID
- Guillaume, Olivier
- Venue
- Biofilm
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 4
- Pages
- 100089
- ISSN
- 2590-2075
- Cited by
- 51
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- FWF
- Technische Universität Wien
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interplay between biofilm microenvironment and pathogenicity of Pseudomonas aeruginosa in cystic fibrosis lung chronic infection. https://app.cochat.ai/papers/10.1016/j.bioflm.2022.100089
- The paper
- Guillaume, O., Butnarasu, C., Visentin, S., & Reimhult, E. (2022). Interplay between biofilm microenvironment and pathogenicity of Pseudomonas aeruginosa in cystic fibrosis lung chronic infection. Biofilm. https://doi.org/10.1016/j.bioflm.2022.100089
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.